4.8 Article

Emerging Strategies for Treating Brain Metastases from Breast Cancer

Journal

CANCER CELL
Volume 27, Issue 2, Pages 163-175

Publisher

CELL PRESS
DOI: 10.1016/j.ccell.2015.01.001

Keywords

-

Funding

  1. US Department of Defense Breast Cancer Research Innovator Award [W81XWH-10-1-0016]
  2. US National Cancer Institute [R01-CA126642, P01-CA080124, R01-CA096915]
  3. Federal Share Proton Beam Program Income
  4. German Research Foundation Grant (Deutsche Forschungsgemeinschaft, DFG) [AS 422-2/1]
  5. Enlight
  6. Ophthotech
  7. SynDevRx

Ask authors/readers for more resources

Brain metastasis is an end stage in breast cancer progression. Traditional treatment options have minimal efficacy, and overall survival is on the order of months. The incidence of brain metastatic disease is increasing with the improved management of systemic disease and prolongation of survival. Unfortunately, the targeted therapies that control systemic disease have diminished efficacy against brain lesions. There are reasons to be optimistic, however, as emerging therapies have shown promise in preclinical and early clinical settings. This review discusses recent advances in breast cancer brain metastasis therapy and potential approaches for successful treatment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available